$6.590
-0.089 (-1.35%)At close
Price Predictions
Open in app to unlock longer-horizon forecasts.
GYRE Prediction & Forecast by Similar Chart Analysis
Alphio's GYRE stock price prediction model matches the current Gyre Therapeutics Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $6.47 (-1.78%). The 1-week path is $6.44 (-2.23%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
Should I Buy Gyre Therapeutics Inc Stock?
Gyre Therapeutics is not a strong buy right now due to its current price of $6.59 and an RSI of 43.445, indicating potential weakness in momentum. The stock has experienced a 4.63% decline over the past 5 days, and the recent widening of losses to $11.66 million in Q2 2026 raises concerns. However, the company has shown revenue growth with a 33.5% year-over-year increase in Q4, which could provide a basis for future recovery.
GYRE stock price ended at $6.59 on Friday, after losing -1.35%
Gyre Therapeutics Inc (GYRE) last closed at $6.59, losing -1.35%. These facts feed the 1-day and 1-week GYRE price prediction above.
Forecast Drivers
Gyre Therapeutics Inc (GYRE) forecast drivers combine similar chart patterns, seasonality, and moving averages.
Similar patterns
Bullish
Seasonality
Bearish
SMA 20
Bearish
SMA 200
Bearish
Similar Chart Patterns
Stocks whose recent price path most closely matches GYRE, ranked by similarity.
Seasonality analysis for GYRE
Historically the probability of a positive August return for GYRE is 6.35%. February offers the highest probability of a positive month at 46.55%, while June is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.